Preoperative versus postoperative docetaxel–cisplatin–fluorouracil (TCF) chemotherapy in locally advanced resectable gastric carcinoma: 10-year follow-up of the SAKK 43/99 phase III trial †
Titel:
Preoperative versus postoperative docetaxel–cisplatin–fluorouracil (TCF) chemotherapy in locally advanced resectable gastric carcinoma: 10-year follow-up of the SAKK 43/99 phase III trial †
Auteur:
Fazio, N. Biffi, R. Maibach, R. Hayoz, S. Thierstein, S. Brauchli, P. Bernhard, J. Stupp, R. Andreoni, B. Renne, G. Crosta, C. Morant, R. Chiappa, A. Luca, F. Zampino, M.G. Huber, O. Goldhirsch, A. de Braud, F. Roth, A.D. Pace, U. Cenciarelli, S. Pozzi, S. Bertani, E. Mura, S. Lorizzo, K. Di Meglio, G. Ravizza, D. Boselli, S. Matter, M. Richter, M. Monfardini, S. Dittrich, C. Häfner, M. Clemens, M.